Ken Seidenman
Senior Associate
Ken Seidenman
Senior Associate
Ken Seidenman is a senior associate in our Melbourne biotechnology team.
He has broad technical expertise in molecular biology, neuroscience, stem cells, drug discovery platforms, antibodies, small molecule therapeutic methods and cancer therapeutics. Ken is also a registered US Patent Agent. Having worked in a number of leading US law firms, Ken’s skills include preparation, prosecution and strategic counselling for biotechnology patent portfolio growth, while also assisting clients with evaluating patent validity, freedom to operate and due diligence matters.
Industry:
Technical Group:
Read Ken's full bio
Education
- Masters of Intellectual Property Law, The University of Melbourne
- Post-Doctoral Fellow, Cold Spring Harbor Laboratory, USA
- PhD in Neuroscience, Northwestern University, USA
- Bachelor of Science in Biochemistry and Molecular Biology, University of Wisconsin-Madison, USA
Industry Expertise
- Stem cells
- CRISPR platform genome editing methods and compositions
- Cancer immunotherapy compositions and methods
- Small molecule drugs, antibodies, proteins, peptides, nucleic acids, and cell therapies for diagnostics including cancer and neurodegenerative disease biomarkers
- Neuroscience, including compositions and devices for treatment of neurodegenerative or neurologic disorders
Professional Affiliations
- Member - The Institute of Patent and Trade Mark Attorneys (IPTA)
- Member - AusBiotech